Author

Iria Baston-Rey 1

1 University Hospital of Santiago de Compostela. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain, Gastroenterology, Santiago de Compostela, Spain

A PROSPECTIVE OBSERVATIONAL COHORT STUDY TO EVALUATE MUCOSAL HEALING IN ULCERATIVE COLITIS: HAVE MAYO 1 AND MAYO 0 SCORES REALLY THE SAME PROGNOSTIC VALUE?

Manuel Barreiro de Acosta, Nicolau Vallejo Senra, Daniel De la Iglesia-García, Laura Uribarri González, Iria Baston-Rey, Rocío Ferreiro-Iglesias, Aurelio Lorenzo-González, Juan Enrique Dominguez-Munoz

ASSOCIATION OF BACTEROIDETES WITH ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

Iria Baston-Rey, Rosa A Sueiro, Manuel Barreiro de Acosta, Laura Uribarri González, Rocio Ferreiro Iglesias, José M leiro, Juan Enrique Dominguez-Munoz

CORRELATION BETWEEN THE PRESENCE OF BACTEROIDETES AND FAECAL CALPROTECTIN FOR THE DETECTION OF ENDOSCOPIC ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Baston-Rey, Rosa A Sueiro, Manuel Barreiro de Acosta, Laura Uribarri González, Rocio Ferreiro Iglesias, José M leiro, Juan Enrique Dominguez-Munoz

DO PSEUDOPOLYPS INCREASE FECAL CALPROTECTIN IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION?

Cristina Calviño Suarez, Manuel Barreiro de Acosta, Violeta Mauriz-Barreiro, Iria Baston-Rey, Daniel de la Iglesia-Garcia, Rocío Ferreiro-Iglesias, J. Enrique Dominguez-Munoz

EFFECTIVENESS AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Maria Chaparro, Sara Sulleiro, Iria Baston-Rey, Ivan Garcia Tercero, Federico Argüelles-Arias, Eduardo Leo, Cristina Rodriguez, Beatriz Sicilia, Patricia Ramírez de la Piscina, Sabino Riestra, Mercedes Cabello, Pilar Corsino, Maria Jose Garcia, Mariana Fé García-Sepulcre, José María Huguet, Pilar Martínez-Montiel, Fernando

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified patients on adalimumab 40 mg every week

Manuel Barreiro-de Acosta, Rocio Ferreiro Iglesias, Andrea Jardi-Cuadrado, Adriano Quiroga-Castiñeira, Iria Baston-Rey, Jaime González, Ana Sousa, Irene Zarra, Juan Enrique Dominguez-Munoz

INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Baston-Rey

INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Iria Baston-Rey, Manuel Barreiro de Acosta, Marta Costa, Cristina Calviño Suarez, Violeta Mauriz-Barreiro, Daniel de la Iglesia-Garcia, Jaime González, Rocío Ferreiro-Iglesias, J. Enrique Dominguez-Munoz

LONG-TERM DURABILITY AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Maria Chaparro, Sara Sulleiro, Iria Baston-Rey, Ivan Garcia Tercero, Federico Argüelles-Arias, Eduardo Leo, Cristina Rodriguez, Beatriz Sicilia, Patricia Ramírez de la Piscina, Sabino Riestra, Mercedes Cabello, Santiago García-López, Maria Jose Garcia, Mariana Fé García-Sepulcre, José María Huguet, Pilar Martínez-Montiel, F

THE INFLUENCE OF PREOPERATIVE MEDICATIONS IN SURGICAL COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE IN SPAIN: A MULTICENTER STUDY OF GETECCU

María José García García, Montserrat Rivero, JOSE MIRANDA BAUTISTA, Iria Baston-Rey, Francisco Mesonero, Eduardo Leo, Diego Casas, Carmen Cagigas Fernández, Ismael El-Hajra, Albert Martin-Cardona, Nerea Hernández-Aretxabaleta, Isabel Pérez-Martínez, Esteban Fuentes-Valenzuela, Nuria Jimenez, Cristina Rubín de Célix, Ana Guti

Item 1 - 10 / 11
1
2